A phase II trial of the first-line erlotinib
The development of a rash has been retrospectively associated with increased response and improved survival...
ادامه مطلبThe development of a rash has been retrospectively associated with increased response and improved survival...
ادامه مطلبErlotinib induced skin toxicity has been associated with clinical benefit in several tumour types. This...
ادامه مطلبThe purpose of this study was to prospectively evaluate the timing of metabolic response monitoring with...
ادامه مطلبZinc is involved in many essential cellular functions, including DNA repair and immune system maintenance....
ادامه مطلبTwenty-one patients with recurrent or progressive glioblastoma were enrolled in a prospective phase II...
ادامه مطلبEvaluation of toxicity and efficacy of an alternating weekly regimen of temozolomide administered 1 week...
ادامه مطلبActivating mutations in EGFR are important markers of response to tyrosine kinase inhibitor (TKI) therapy...
ادامه مطلبWe conducted a randomized, placebo-controlled, double-blind trial to determine whether the epidermal...
ادامه مطلبThe efficacy of temozolomide (TMZ) in recurrent glioblastoma multiforme (GBM) has been evaluated by several...
ادامه مطلبNumerous studies have reported the clinical efficacy of temozolomide (TMZ) treatment for highgrade glioma,...
ادامه مطلبRadiotherapy with concomitant and adjuvant temozolomide is the standard of care for newly diagnosed glioblastoma...
ادامه مطلبBackground High grade glioma (HGG) is an aggressive form of brain cancer. Treatment of HGG usually entails...
ادامه مطلب